Vaught JL - Search Results

1

McN-5652: a highly potent inhibitor of serotonin uptake.

Shank RP, Vaught JL, Pelley KA, Setler PE, McComsey DF, Maryanoff BE. Shank RP, et al. Among authors: vaught jl. J Pharmacol Exp Ther. 1988 Dec;247(3):1032-8. J Pharmacol Exp Ther. 1988. PMID: 2905001

2

Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Raffa RB, et al. Among authors: vaught jl. J Pharmacol Exp Ther. 1992 Jan;260(1):275-85. J Pharmacol Exp Ther. 1992. PMID: 1309873

3

Etoperidone, trazodone and MCPP: in vitro and in vivo identification of serotonin 5-HT1A (antagonistic) activity.

Raffa RB, Shank RP, Vaught JL. Raffa RB, et al. Among authors: vaught jl. Psychopharmacology (Berl). 1992;108(3):320-6. doi: 10.1007/BF02245118. Psychopharmacology (Berl). 1992. PMID: 1387963

4

Antinociceptive action of McN-5195 in rodents: a structurally novel (indolizine) analgesic with a nonopioid mechanism of action.

Vaught JL, Carson JR, Carmosin RJ, Blum PS, Persico FJ, Hageman WE, Shank RP, Raffa RB. Vaught JL, et al. J Pharmacol Exp Ther. 1990 Oct;255(1):1-10. J Pharmacol Exp Ther. 1990. PMID: 2170621

5

Pyrroloisoquinoline antidepressants. 3. A focus on serotonin.

Maryanoff BE, Vaught JL, Shank RP, McComsey DF, Costanzo MJ, Nortey SO. Maryanoff BE, et al. Among authors: vaught jl. J Med Chem. 1990 Oct;33(10):2793-7. doi: 10.1021/jm00172a018. J Med Chem. 1990. PMID: 2213832

6

Preclinical evaluation of McN-5707 as a potential antidepressant.

Shank RP, Gardocki JF, Schneider CR, Vaught JL, Setler PE, Maryanoff BE, McComsey DF. Shank RP, et al. Among authors: vaught jl. J Pharmacol Exp Ther. 1987 Jul;242(1):74-84. J Pharmacol Exp Ther. 1987. PMID: 3039115

7

Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.

Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, Jacoby HI, Selve N. Raffa RB, et al. Among authors: vaught jl. J Pharmacol Exp Ther. 1993 Oct;267(1):331-40. J Pharmacol Exp Ther. 1993. PMID: 8229760

8

The novel anticonvulsant loreclezole (R 72063) does not produce diazepam-like anterograde amnesia in a passive avoidance test in rats.

Raffa RB, Vaught JL, Setler PE. Raffa RB, et al. Among authors: vaught jl. Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):613-5. doi: 10.1007/BF00169053. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2090955

9

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

Shank RP, Gardocki JF, Vaught JL, Davis CB, Schupsky JJ, Raffa RB, Dodgson SJ, Nortey SO, Maryanoff BE. Shank RP, et al. Among authors: vaught jl. Epilepsia. 1994 Mar-Apr;35(2):450-60. doi: 10.1111/j.1528-1157.1994.tb02459.x. Epilepsia. 1994. PMID: 8156972

10

Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors.

Reitz AB, Baxter EW, Codd EE, Davis CB, Jordan AD, Maryanoff BE, Maryanoff CA, McDonnell ME, Powell ET, Renzi MJ, Schott MR, Scott MK, Shank RP, Vaught JL. Reitz AB, et al. Among authors: vaught jl. J Med Chem. 1998 Jun 4;41(12):1997-2009. doi: 10.1021/jm970164z. J Med Chem. 1998. PMID: 9622541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page